SCHEMBL6980347

SCHEMBL6980347

O=c1[nH]c2ccccc2c(=O)n1-c1cccc(Cl)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 1.00
GAA P10253 2/20 1.00
TP53 P04637 1/20 0.72
HTT P42858 1/20 0.66
ALDH1A1 P00352 3/20 0.64
SMN1; SMN2 Q16637 2/20 0.64
HPGD P15428 2/20 0.64
HIF1A Q16665 1/20 0.64
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
MAPT P10636 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
KMT2A Q03164 2/20 0.56
NPEPPS P55786 2/20 0.56
MEN1 O00255 1/20 0.56
LMNA P02545 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5334816 0.88 KDM4E (0.78) KDM4EGAATP53HTTALDH1A1
SCHEMBL6974482 0.88 KDM4E (0.78) KDM4EGAATP53HTTALDH1A1
SCHEMBL6977596 0.84 KDM4E (0.73) KDM4EGAATP53HTTALDH1A1
SCHEMBL10743256 0.84 KDM4E (0.73) KDM4EGAATP53HTTALDH1A1
SCHEMBL6981446 0.84 KDM4E (0.71) KDM4EGAATP53HTTALDH1A1
SCHEMBL6981508 0.84 KDM4E (0.72) KDM4EGAATP53HTTALDH1A1
SCHEMBL6975203 0.84 KDM4E (0.72) KDM4EGAATP53HTTALDH1A1
SCHEMBL6980789 0.84 TP53 (1.00) KDM4EGAATP53HTTALDH1A1
SCHEMBL8480237 0.82 MEN1 (0.73) KDM4EGAATP53HTTALDH1A1
SCHEMBL6979777 0.81 KDM4E (0.68) KDM4EGAATP53ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030199530-A1 New compounds derived from quinazoline LES LABORATORIES SERVIER (FR) 2003-10-23 US disclosed
EP-1346992-A1 Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2003-09-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199530-A1 New compounds derived from quinazoline NQO2, XDH, DRD1 KDM4E 4217/4885GAA 638/4885TP53 3198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.